Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: Evidence for Erk-1/2 activation

Blood

Volumn 97, Issue 3, 2001, Pages 692-699

  Nishibe, Toshiya ^b   Parry, Graham ^b   Ishida, Atsushi ^b   Aziz, Salim ^b   Murray, Jacqueline ^b   Patel, Yatin ^b   Rahman, Salman ^b   Strand, Kurt ^b   Saito, Keiko ^b   Saito, Yuji ^b   Hammond, William P ^b   Savidge, Geoffrey F ^b   Mackman, Nigel ^b   Wijelath, Errol S ^a  

^a HOPE HEART INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; ONCOSTATIN M; THROMBOPLASTIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0035254313     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.3.692     Document Type: Article

References (54)

1. Tissue factor in the pathogenesis of atherosclerosis
2. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury
3. Developmental mechanisms underlying pathology of arteries
4. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits
5. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries
6. Localization and activity of tissue factor in human aortic atherosclerotic lesions
7. Identification of active tissue factor in human coronary atheroma
8. Tissue factor and hemostasis
9. The structural biology of expression and function of tissue factor
10. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X
11. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
12. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
13. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
14. Tissue factor expression in human arterial smooth muscle cells: TF is present in three cellular pools after growth factor stimulation
15. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
16. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions
17. Neuropoietic cytokines in the hematopoietic fold
18. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6
19. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
20. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells
21. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M
22. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells
23. Regulation of IL-6 expression by oncostatin M
24. Regulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor expression by oncostatin M
25. Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts
26. Stimulation of TIMP-1 production by oncostatin M in human articular cartilage
27. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
28. Oncostatin M is a proinflammatory mediator: In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules
29. Oncostatin M induces angiogenesis in vitro and in vivo
30. Monoclonal antibody analysis of purified and cell-associated tissue factor
31. Functional analysis of the human tissue factor promoter and induction by serum
32. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model
33. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
34. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites
35. The unstable atherosclerotic plaque: Clinical significance and therapeutic intervention
36. Atherosclerosis - An inflammatory disease
37. Transcriptional regulation of tissue factor expression in human endothelial cells
38. Oncostatin M regulation of interleukin-6 expression in astrocytes: Biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38
39. French multicentric evaluation of recombinant tissue factor (recombiplastin) for determination of prothrombin time
40. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes
41. Induction of the urokinase plasminogen activator system by oncostatin M promotes endothelial migration
42. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology
43. Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells
44. Regulation of the tissue factor gene
45. Regulation of the tissue factor gene in human monocytic cells: Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression
46. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers
47. Fluid shear stress induction of the tissue factor promoter in Vitro and in vivo is mediated by Egr-1
48. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation
49. The NF-kappa B and I kappa B proteins: New discoveries and insights
50. Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha
51. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
52. Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells: Evidence for additional regulatory steps in kappaB-dependent transcription
53. Mechanistic aspects of NF-kappa B regulation: The emerging role of phosphorylation and proteolysis
54. Activation of NF-kappa B in vivo is regulated by multiple phosphorylations